Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 3

TABLE OF CONTENTS Volume 19, Issue 3 (March 2012) In this issue Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take a look at this recent article in The European Journal of Human Genetics: Clinical utility gene card for: Werner syndrome FREE Fuki M Hisama , Christian Kubisch , George M Martin & Junko Oshima European Journal of Human Genetics doi:10.1038/ejhg.2011.265   Review Top Targeting 14-3-3zeta in cancer therapy X Yang, W Cao, L Zhang, W Zhang, X Zhang and H Lin Cancer Gene Ther 2012 19: 153-159; advance online publication, December 23, 2011; 10.1038/cgt.2011.85 Abstract | Full Text Original Articles Top Oncolytic Herpes simplex virus expressing yeast cytosine deaminase: relationship between viral replication, transgene expression, prodrug bioactivation S Yamada, T Kuroda, B C Fuchs, X He, J G Supko, A Schmitt, C M McGinn, M Lanuti and K K Tanabe Cancer Gene Ther 2012 19: 160-170; advance online publication, November 11, 2011; 10.1038/cgt.2011.70 Abstract | Full Text Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors Z-K Liao, K-C Tsai, H-T Wang, S-H Tseng, W-P Deng, W-S Chen and L-H Hwang Cancer Gene Ther 2012 19: 171-180; advance online publication, November 18, 2011; 10.1038/cgt.2011.73 Abstract | Full Text Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus K Zaoui, S Bossow, C Grossardt, M F Leber, C Springfeld, P K Plinkert, C von Kalle and G Ungerechts Cancer Gene Ther 2012 19: 181-191; advance online publication, November 11, 2011; 10.1038/cgt.2011.75 Abstract | Full Text Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer M Sathaiah, P Thirunavukkarasu, M E O'Malley, M A Kavanagh, R Ravindranathan, F Austin, Z S Guo and D L Bartlett Cancer Gene Ther 2012 19: 192-201; advance online publication, November 25, 2011; 10.1038/cgt.2011.77 Abstract | Full Text Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus Y-P Liu, C Tong, A Dispenzieri, M J Federspiel, S J Russell and K-W Peng Cancer Gene Ther 2012 19: 202-211; advance online publication, November 25, 2011; 10.1038/cgt.2011.82 Abstract | Full Text Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma N Rainusso, V S Brawley, A Ghazi, M J Hicks, S Gottschalk, J M Rosen and N Ahmed Cancer Gene Ther 2012 19: 212-217; advance online publication, December 16, 2011; 10.1038/cgt.2011.83 Abstract | Full Text Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed Q Li, K Kawamura, M Yamanaka, S Okamoto, S Yang, S Yamauchi, T Fukamachi, H Kobayashi, Y Tada, Y Takiguchi, K Tatsumi, H Shimada, K Hiroshima and M Tagawa Cancer Gene Ther 2012 19: 218-228; advance online publication, January 6, 2012; 10.1038/cgt.2011.86 Abstract | Full Text Advertisement Nature Reviews Genetics ANIMATION ON RNA INTERFERENCE Nature Reviews Genetics, in association with Arkitek Studios, has brought RNAi to life in this vivid, audio-visual journey into the cell. See RNAi in action by viewing the animation for FREE at: www.nature.com/nrg/multimedia/rnai Produced with support from Thermo Scientific   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.